These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9420523)

  • 1. Invited commentary: le mystère de Montréal.
    Lurie P
    Am J Epidemiol; 1997 Dec; 146(12):1003-6; discussion 1007-10. PubMed ID: 9420523
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Invited commentary: le mystère de Montréal".
    Hahn J; Moss A; Vranizan K
    Am J Epidemiol; 1998 Oct; 148(7):714; author reply 715-6. PubMed ID: 9778179
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: "Invited commentary: le mystère de Montréal".
    Fisher DG; Bigelow C
    Am J Epidemiol; 1998 Oct; 148(7):714-5; author reply 715-7. PubMed ID: 9778180
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study".
    Garfein RS; Lyerla R; Jones TS; Nakashima AK; Monterroso ER; Vlahov D
    Am J Epidemiol; 1999 Aug; 150(3):325-6. PubMed ID: 10430240
    [No Abstract]   [Full Text] [Related]  

  • 5. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.
    Bruneau J; Lamothe F; Franco E; Lachance N; Désy M; Soto J; Vincelette J
    Am J Epidemiol; 1997 Dec; 146(12):994-1002. PubMed ID: 9420522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for evaluating needle exchange programmes.
    Kaplan EH
    Stat Med; 1994 Oct 15-30; 13(19-20):2179-87. PubMed ID: 7846418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: "High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study".
    Lowndes CM; Alary M
    Am J Epidemiol; 1998 Oct; 148(7):713-4; author reply 716-7. PubMed ID: 9778178
    [No Abstract]   [Full Text] [Related]  

  • 9. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking coverage of needle exchange programs.
    Burrows D
    Subst Use Misuse; 2006; 41(6-7):1045-8. PubMed ID: 16809186
    [No Abstract]   [Full Text] [Related]  

  • 11. Syringe-exchange programs in the United States: where are we now?
    Paone D; Des Jarlais D; Clark J; Shi Q
    AIDS Public Policy J; 1996; 11(3):144-7. PubMed ID: 10915246
    [No Abstract]   [Full Text] [Related]  

  • 12. Syringe exchange proposal.
    Jacobs RE
    N J Med; 2002 Dec; 99(12):33-4. PubMed ID: 12510571
    [No Abstract]   [Full Text] [Related]  

  • 13. Needle and syringe exchange programs in Amsterdam.
    Witteveen E; Schippers G
    Subst Use Misuse; 2006; 41(6-7):835-6. PubMed ID: 16809172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drugs, Poverty and HIV: results regarding a provincial needle exchange program in Point de Repères, Quebec].
    Bélanger D; Noël L; Alary M; Parent R; Poulin C; Claessens C
    Can J Public Health; 2000; 91(3):176-80. PubMed ID: 10927843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use and HIV risk practices of secondary and primary needle exchange users.
    Huo D; Bailey SL; Hershow RC; Ouellet L
    AIDS Educ Prev; 2005 Apr; 17(2):170-84. PubMed ID: 15899754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe exchange use and HIV risk reduction over time.
    Paone D; Des Jarlais DC; Shi Q
    AIDS; 1998 Jan; 12(1):121-3. PubMed ID: 9456269
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost effectiveness of SEPs.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151-2. PubMed ID: 11361923
    [No Abstract]   [Full Text] [Related]  

  • 18. Critical condition facing needle exchange programs: the politics of science.
    Sherman SG
    Subst Use Misuse; 2006; 41(6-7):827-9. PubMed ID: 16809169
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canada's drug problem: time to get serious.
    Voth EA
    CMAJ; 1999 Feb; 160(4):477, 479. PubMed ID: 10081460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.